From Trials to Treatments - Making it Seamless
Commercialization—the transition from clinical trials to market—is one of the most complex phases in drug development, not least when the launch of the therapeutic relies on global market access to the CDx. This transition from trial-to-market is critical because it involves bridging scientific rigor with operational execution, ensuring patients receive therapies quickly and safely. Sponsors and CROs need a ’single-source’ partner to bridge the gap between clinical trials and commercialization integrated lab services, global logistics, and advanced technology—instead of integrating multiple vendors.
IVDR
Compliant
Global
Standardization
Rapid
Logistics
Call Center
Support
Patient
Privacy
Our Clinical Trials & Commercialization Capabilities
LabConnect accelerates the transition from clinical trials to market with end-to-end laboratory and logistics solutions. Our team provides scientific consulting, assay validation, and biomarker strategy to ensure regulatory readiness for product launch. We deliver global distribution and customs expertise, including GMP-compliant depots and real-time tracking, combined with AI-powered data harmonization and integrated technology platforms. It’s one seamless solution, all from one partner.
Partner With Us
Request a quote from our dedicated team by filling out the form today.
